Position in CLYM
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$142,136
+$39,896 QoQ
Shares Held
10,900
-80.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 108 holders
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLYM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILARD, INC. holds $23,164,134 across 15 Biotechnology names. CLYM ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,314 | $18,534,983 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,376 | $2,105,071 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
1,400 | $442,526 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
6,277 | $295,270 | |
| 5 | INVA |
Innoviva, Inc.
|
10,933 | $248,288 | |
| 6 | ERAS |
Erasca, Inc.
|
13,146 | $240,834 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
|
14,700 | $210,798 | |
| 8 | ARTV |
Artiva Biotherapeutics, Inc.
|
20,700 | $200,790 |
All Filings in CLYM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,136 | 10,900 | Shares | Sole | 2026-07-30 | |
| 2024-12-31 | $102,240 | 56,800 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||